108Labs
108Labs is a biotechnology company that develops the M2 Magic of Milk Platform, an AI-enabled smart bioreactor for producing cell-cultured milks. It licenses the platform and sub-brands to enterprise partners in food, infant formula, and therapeutic sectors.
- Company typePrivate
- Founded2013
- HeadquartersHillsborough, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
108Labs firmographics
Firmographics- Name
- 108Labs
- Legal name
- 108Labs LLC
- Website
- https://108labs.net
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- 108Labs is a biotechnology company that develops the M2 Magic of Milk Platform, an AI-enabled smart bioreactor for producing cell-cultured milks. It licenses the platform and sub-brands to enterprise partners in food, infant formula, and therapeutic sectors.
- Ownership category
- akta.pro rank
108Labs industry classification
Industry- Product category
- Cell-cultured dairy biotechnology
- NAICS
- Fluid Milk Manufacturing (311511), Dairy Product (except Frozen) Manufacturing (31151)
- SIC
- Dairy Products (2020)
- akta.pro primary industry
- Fluid Milk & Cream Processing (AFAKAKAA)
- akta.pro secondary industries
- Standard Infant Formula Manufacturing (Cow Milk–Based) (AFAHAHAA), Human Milk Fortifier (HMF) Manufacturing (Bovine-Derived) (AFAHAHAI)
Keywords
Where 108Labs is headquartered
LocationHeadquarters
- HQ city
- Hillsborough
- HQ country
- United States
- HQ region
- North America
Markets served
108Labs business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations
Revenue model
- Technology Licensing: Licensing the M2 Magic of Milk Platform and associated technologies (M2 Colostrupedics, M2 Health, M2 Foods) to corporate partners in food, infant formula, and medicine industries.
- Cell-Cultured Dairy Product Sales: Developing and selling cell-cultured dairy foods until dairy cows can retire to pasture.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels2 records
108Labs product offering
Product offeringCore offering
108Labs develops the M2 Magic of Milk Platform, a turnkey AI-enabled smart bioreactor system that supports autonomous cell feeding, autonomous milking, and continuous monitoring for cell-cultured milk production. Built on this platform, the company pursues three product divisions: M2 Foods (cell-cultured dairy foods), M2 Colostrupedics (humanized infant formula with corporate partners), and M2 Health (human milk therapeutics, beginning with Human Lactoferrin with HMO glycans).
Differentiator
Problem solved
Functional benefit
Brands
- M2 Foods: Cell-cultured dairy foods development until dairy cows can retire out to pasture
- M2 Colostrupedics
- M2 Health
- M2 Magic of Milk Platform
Products and services
- M2 Magic of Milk Platform
- M2 Foods
- M2 Colostrupedics
- M2 Health
Quantifiable outcome
- Global scale production of cell-cultured milks at low cost
Companies that use 108Labs
Customer profileSegments3 records
Ideal customer profiles3 records
108Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability1 record
Feature4 records
108Labs partnerships and signals
Strategic signalScale indicators1 record
108Labs competitors and assessment
Company assessmentDirect peers
- Perfect Day: Perfect Day is the most capitalized player in cell-cultured/precision-fermentation dairy proteins (whey, casein). They share 108Labs' cell-cultured dairy commercial ambition and target the same food and nutrition customers.
- Remilk: Remilk produces animal-free dairy proteins via precision fermentation and targets food and beverage applications. It competes with 108Labs in the alternative-protein dairy market with comparable end customers.
- TurtleTree Labs: TurtleTree produces cell-cultured milk and milk proteins using mammary cell technology, later pivoting to sustainable functional ingredients. They compete head-on with 108Labs' M2 Foods and platform approach to cell-cultured dairy.
- Biomilq: Biomilq cultivates human milk components directly from mammary cells, the same foundational approach (Mammary Cellufacturing) that 108Labs uses. Both target infant nutrition/infant formula applications with cell-cultured mammary-cell technology, making them the most directly comparable peer.
Others
- Nourish Ingredients: Nourish Ingredients produces cell-cultured alternative fats and ingredients via precision fermentation. They are adjacent in cell-based food technology, sharing infrastructure and regulatory pathways relevant to 108Labs' mammalian cell platform.
Emerging players
- Helaina: Helaina uses precision fermentation to produce human lactoferrin, directly overlapping with 108Labs' M2 Health Human Lactoferrin with HMO glycans therapeutic program. They target infant nutrition and functional foods as customers.
- Wilk (formerly Biomilk): Wilk develops cultured milk fat and dairy ingredients from cell-based platforms, competing in cell-cultured dairy components alongside 108Labs' M2 Foods product line.
- Cultivated Biosciences: Cultivated Biosciences produces cell-cultured dairy fats and other functional dairy ingredients for plant-based and traditional food applications, an emerging niche overlap with 108Labs' alternative dairy ambitions.
Market position
Customer concentration
108Labs social profiles
Digital presence108Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
108Labs leadership team
Management profileNumber of profiles
108Labs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
108Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about 108Labs
What does 108Labs do?
108Labs develops the M2 Magic of Milk Platform, a turnkey AI-enabled smart bioreactor system that supports autonomous cell feeding, autonomous milking, and continuous monitoring for cell-cultured milk production. Built on this platform, the company pursues three product divisions: M2 Foods (cell-cultured dairy foods), M2 Colostrupedics (humanized infant formula with corporate partners), and M2 Health (human milk therapeutics, beginning with Human Lactoferrin with HMO glycans).
Is 108Labs a public or private company?
108Labs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was 108Labs founded?
108Labs was founded in 2013. It employs 1 to 10 people.
Where is 108Labs based?
108Labs is headquartered in Hillsborough, United States, in the North America region.
How does 108Labs make money?
Two revenue lines are on record. Technology Licensing is the primary driver. The others are cell-Cultured Dairy Product Sales.
Who are 108Labs's main competitors?
Direct peers on record are Perfect Day, Remilk, TurtleTree Labs and Biomilq. Nourish Ingredients is listed as an others. Emerging players are Helaina, Wilk (formerly Biomilk) and Cultivated Biosciences.
Does 108Labs have an API?
No public API is recorded for 108Labs.
What industry is 108Labs in?
108Labs's product category is Cell-cultured dairy biotechnology. Its primary akta.pro industry code is AFAKAKAA, Fluid Milk & Cream Processing, with a secondary code of AFAHAHAA, Standard Infant Formula Manufacturing (Cow Milk–Based). Its NAICS code is 311511 and its SIC code is 2020.